Iran vs Other small states: Immunization, Hib3 (% of children ages 12-23 months)
Iran
98.0%
in 2024
Other small states
85.6%
in 2024
Iran rank
20th
Other small states rank
18th
Immunization, Hib3 (% of children ages 12-23 months) over time
- Iran
- Other small states
How they compare
Iran currently reports 98.0% against 85.6% in Other small states, a difference of 12.4%.
That makes Iran's figure about 1.1 times Other small states's.
Across all 10 years both countries report, Iran has been ahead every year.
Iran ranks 20th and Other small states ranks 18th of 191 countries.
Iran has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Iran | Other small states | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 98.8% | 88.6% | 10.2% | Iran |
| 2020s | 98.6% | 85.3% | 13.3% | Iran |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher immunization, hib3, Iran or Other small states?
- Iran, at 98.0% against 85.6% in Other small states as of 2024.
- What is the difference in immunization, hib3 between Iran and Other small states?
- 12.4%, with Iran ahead.
- How many years of comparable data are there for Iran and Other small states?
- 10 years are reported by both, from 2015 to 2024.
- How do Iran and Other small states rank globally for immunization, hib3?
- Iran ranks 20th and Other small states ranks 18th of 191 countries.
- Where does this data come from?
- WHO and UNICEF (http://www.who.int/immunization/monitoring_surveillance/en/), published as Immunization, Hib3 (% of children ages 12-23 months). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Child immunization, Hib3, measures the percentage of children ages 12-23 months who received Hib3 vaccinations before 12 months or at any time before the survey. A child is considered adequately immunized against Hib3 after receiving three doses of Haemophilus influenzae type b vaccine.